Institutional investors purchased a net $3.4 million shares of EXAS during the quarter ended March 2015 and now own 99.22% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE AG Bought 1.5 Thousand shares of Exact Sciences Corp